FDA recall, , Moderate risk
Charger for the Therabody Theragun, G4 PRO Massage Device
The charger for the Theragun G4 PRO may overheat, posing a fire risk.
Summary by Recall Canary from the FDA notice
What happened
Therabody, Inc. of Los Angeles, California, recalled chargers for the Theragun G4 PRO massage device because the charging cradle may overheat while charging the device's removable battery pack, presenting a risk of thermal event (fire). The firm received reports alleging the product caught fire and other reports regarding visible smoke, melting, charger burn, burning odor, and overheating.
The recall began June 23, 2026, and the FDA added it to its Enforcement Report on July 31, 2026. The product was distributed nationwide in the US.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:
- A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
- Talk to your health care provider before you stop using it.
Is yours affected?
Compare the details below with your product and check the FDA notice to confirm whether it is affected.
A UDI-DI is the device identifier printed with the barcode on the device label.
G4 Pro Black US - Refurb.
- SKU
- TG02428-01
- UDI-DI
- 00810036050135
- 810036051378
- Lot code
- All lots are recalled
G4 Pro NA
- SKU
- G4-PRO-PKG-NA
G4-Pro-PKG-US
- SKU
- G4 PRO US
G4 Pro Black US - Refurb V
- SKU
- TG0002428-1V10
Recall details
- Company began the recall
- Sold in
Worldwide - US Nationwide distribution.
- Company
- Therabody, IncLos Angeles, California
- Hazard
- Device defect
- Risk
Moderate risk
Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99281
- Recall number
- Z-2835-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
